Sleep Apnea in Heart Failure: What to Know About OSA, Central Apnea, and CPAP

You have been told you have heart failure, or atrial fibrillation, and somewhere in the conversation a sleep study came up. Maybe your spouse mentioned the gasping. Maybe you wake up with a headache and feel wrung out by mid-afternoon. Maybe you snore loud enough to wake yourself, and your partner has stopped sleeping in the same room. If any of that sounds familiar, the sleep study is not a side quest. It is part of your heart care, and there is good reason your cardiologist asked.

Sleep apnea sits at one of the most under-treated intersections in cardiology. Roughly half to three-quarters of patients with heart failure have some form of sleep-disordered breathing, and most of them do not know it. The fatigue gets blamed on the heart. The morning headache gets blamed on the blood pressure pills. The brain fog gets blamed on aging. A sleep study cuts through that noise and tells you whether your nights are part of why your days are hard.

This article walks you through why sleep apnea matters in heart failure, the two flavors we see in cardiology patients, how each worsens the heart, what to expect from a sleep study, what CPAP can and cannot do, and the cautionary story behind one machine that turned out to be a mistake in a specific group.

Why We Ask Heart Failure Patients About Sleep

Sleep apnea is common in the general population. In heart failure it is the rule. About half of patients with heart failure with reduced pump function (HFrEF) have meaningful sleep apnea, and so do about half to three-quarters of patients with heart failure with preserved pump function (HFpEF). In atrial fibrillation patients the rate is similar, sometimes higher.

Most of these patients are undiagnosed when I meet them. Sleep apnea announces itself at night, when no one is watching except a tired spouse. Daytime symptoms are vague. People adapt to feeling bad in the morning, drink more coffee, blame the rough sleep on stress. By the time the heart starts to fail, the apnea has been chipping away at things for years.

Untreated sleep apnea makes heart failure worse, makes blood pressure harder to control, makes atrial fibrillation more likely to come back after we treat it, and makes you feel terrible during the day. Treating it does not fix the heart on its own. It takes a wrench out of the gears. That is why the sleep question keeps coming up at your visits.

The Two Kinds of Sleep Apnea: Obstructive and Central

When cardiologists talk about sleep apnea, we are usually talking about one of two patterns. They look similar from the outside. Inside the chest they are different problems, and they are treated differently.

The first is obstructive sleep apnea (OSA). This is the kind most people picture. Your airway at the back of your throat collapses partly or fully when the muscles relax during sleep. You try to breathe in, the airway is blocked, your chest and belly work hard against a closed door, and your oxygen drops. Your brain wakes you up just enough to clench the airway open again, you take a noisy breath, and you fall back asleep without remembering any of it. People with OSA can have this cycle dozens or hundreds of times a night. Snoring is loud. The pause is followed by a gasp or a snort. Bed partners are usually the ones who notice.

The second is central sleep apnea (CSA). This one is different. The airway is open. The brain stops sending the breathe signal for a stretch, so the chest goes quiet. No effort, no snore, just stillness, then a stretch of breathing again. CSA shows up much more often in heart failure than in the general population. It is a sign that the breathing control system has gotten unstable, often because of the heart itself.

A lot of heart failure patients have both at once. We call that mixed sleep apnea. The split between obstructive and central matters because the treatment is different, and getting it wrong can cause harm. That is why the sleep study is worth doing properly rather than guessing.

One more piece of vocabulary worth knowing. A full breathing pause is called an apnea. A shallow breathing pause that drops your oxygen or fragments your sleep is sometimes called a hypopnea, and I will refer to it here as a shallow breathing pause. The sleep study counts both per hour and gives you a number called the AHI, the count of breathing pauses per hour of sleep. An AHI of 5 to 14 is mild, 15 to 29 is moderate, and 30 or higher is severe. Heart failure patients with an AHI above 15 usually need treatment.

Cheyne-Stokes Breathing: What Your Partner Might Notice

A specific pattern of central sleep apnea shows up in heart failure often enough to deserve its own name. It is called Cheyne-Stokes breathing, and it has a signature your bed partner may have already described to you without using the term.

The pattern goes like this. The breathing builds up gradually, getting deeper and faster over thirty seconds or so. It peaks. Then it tapers down, getting shallower, until the chest goes still for ten to thirty seconds. The cycle starts again. The deep-shallow-pause-deep rhythm repeats over and over through the night. To a partner watching, it can be alarming.

Cheyne-Stokes breathing is a sign that the heart is not pumping efficiently and the breathing control system is overshooting in response. Blood travels more slowly between the lungs and the brain when the heart is weak, so the brain gets a delayed read on the carbon dioxide level in the blood. The lungs overcorrect, then undercorrect. That oscillation produces the cycling pattern. Patients with Cheyne-Stokes have a worse prognosis on average than patients without it. If your partner has described breathing as coming in waves with long pauses between, tell your cardiologist. It changes what kind of sleep study you need.

How Sleep Apnea Actually Worsens Heart Failure

It is one thing to say sleep apnea is bad for the heart. It helps to understand why, because the mechanisms make the symptom story click. There are a handful of ways untreated apnea wears the heart down.

Oxygen swings. Each pause drops your blood oxygen, sometimes into the low 80s or 70s. Each restart pulls it back up. Doing that fifty or a hundred times a night exposes the heart and the blood vessel lining to repeated cycles of low oxygen and reoxygenation. That kind of stress is hard on the inner walls of arteries and on the heart muscle itself.

Stress-hormone spikes. Every arousal at the end of an apnea is a small alarm in the nervous system. Your fight-or-flight branch fires. Adrenaline and related stress hormones rise. Heart rate jumps. Blood pressure spikes. Sleep is supposed to be the time your cardiovascular system rests. In severe apnea, your heart spends much of the night running a low-grade workout it cannot recover from.

Pressure swings inside the chest. When your throat closes off and you keep trying to breathe in, your chest pulls hard against a vacuum. The pressure inside the chest swings way negative. That sucks blood toward the right side of the heart, stretches the chambers, and forces the left side to pump against a higher resistance. Over time, repeated stretching of the heart chambers helps remodel the heart in directions we do not want, including enlarging the upper chambers and worsening leaky valves.

Atrial fibrillation generation. The combination of low oxygen, stress hormones, and pressure swings is a near-perfect recipe for triggering atrial fibrillation. The upper chambers get stretched, irritated, and electrically jumpy in a single night. People with severe OSA are roughly two to four times more likely to develop AFib than people without, and untreated apnea makes AFib much harder to keep away once it starts.

Blood pressure that will not budge. Untreated sleep apnea is one of the most common reasons we cannot get blood pressure down with medication alone. The night-time stress reaction carries into the day. Patients on three or four blood pressure pills who still run high should be asked about their sleep.

Sleep Apnea and AFib: The Tightest Cardiology-Sleep Link

If there is one cardiac diagnosis where I cannot afford to miss the sleep apnea, it is atrial fibrillation. The link between AFib and sleep apnea is tight, dose-dependent, and clinically actionable.

Patients with moderate to severe OSA have higher rates of AFib than the general population, and the rate climbs with apnea severity. After we treat AFib with a catheter ablation, untreated sleep apnea roughly doubles the chance of AFib coming back over the next year. Patients on CPAP who use it consistently after ablation have recurrence rates that look much closer to patients without sleep apnea at all. The rough numbers: untreated apnea around 50 percent recurrence at one year, treated apnea around 25 to 30 percent, no apnea around 25 percent. CPAP brings the apnea group back into the no-apnea neighborhood.

For a patient considering ablation, that is a real number. Letting untreated apnea reverse the result over the following year is a poor outcome we can prevent. I screen every AFib patient for sleep apnea. The 2023 atrial fibrillation guideline backs that up. If you have AFib and have not been asked about your sleep, ask your cardiologist. Apnea treatment is part of AFib treatment.

Screening: STOP-BANG, Epworth, and Where They Fall Short

A few short questionnaires get used in clinic to figure out who is likely to have sleep apnea. They are useful filters. They are not perfect, and in heart failure patients they are less reliable than in the general population. Worth knowing both sides.

The STOP-BANG questionnaire is eight yes-or-no items: Snoring, Tiredness, Observed apnea, blood Pressure, BMI over 35, Age over 50, Neck circumference over 40 cm, Gender (male). Three or more yes answers makes obstructive sleep apnea likely. Five or more makes it very likely. The score is fast and reasonably accurate as a triage tool in a typical clinic.

The Epworth Sleepiness Scale asks how likely you are to doze off in eight everyday situations: reading, watching TV, sitting in a meeting, riding in a car, lying down after lunch, and so on. Each gets a 0 to 3 score. A total over 10 suggests you are sleepier than you should be, which fits with apnea among other causes.

Here is the catch in heart failure. Heart failure patients with central sleep apnea often score low on Epworth. They do not feel sleepy during the day. They feel exhausted, but in a heavy, can-not-get-going way rather than a dozing-off way. STOP-BANG misses central sleep apnea too, since it is built around the obstructive pattern: snoring, neck size, observed gasping. A heart failure patient with pure central sleep apnea may pass both questionnaires and still have severe disease.

For that reason, in heart failure I lower the threshold for ordering a sleep study. If you have HFrEF or HFpEF and any combination of unexplained fatigue, witnessed pauses in breathing at night, AFib, blood pressure that will not come down, or a partner who has noticed the breathing patterns described above, that is enough for me to order the study. The questionnaires are not meant to be the gatekeeper in this population.

Home Sleep Test or In-Lab Study: Which One You Need

Sleep studies come in two main formats. Choosing the right one matters in heart failure, and the wrong one can miss the diagnosis you actually have.

A home sleep test is a simplified setup you wear for one to three nights at home. It typically records your airflow, oxygen, breathing effort through a chest band, and heart rate. It is comfortable and convenient. It does a good job of finding moderate to severe obstructive sleep apnea in people without much else going on.

An in-lab sleep study, called polysomnography, is the full version. You spend a night at a sleep center wired up with a fuller array of sensors: brain waves, eye movements, leg movements, several breathing channels, oxygen, heart rhythm, video. The brain wave channels let the technician separate true sleep from time spent lying awake, and they capture the structure of your sleep. The full breathing recording lets the reader tell central from obstructive events with confidence.

In heart failure, I lean strongly toward the in-lab study on the first pass. Home tests can miss central sleep apnea or count central events as obstructive, since they have less information to work with. The wrong call sends a patient home with the wrong machine. Home tests are reasonable for screening when access to in-lab beds is limited, and reasonable for follow-up after treatment is established.

CPAP in Heart Failure: Who It Helps and How Much

Continuous positive airway pressure (CPAP) is the workhorse treatment for obstructive sleep apnea, and it works in heart failure patients with OSA. The machine pushes a steady column of air through a mask, holding the airway open so the muscles cannot collapse it. The pauses go away. The oxygen swings smooth out. The arousals stop fragmenting your sleep.

In heart failure patients with OSA, regular CPAP use does several things at once. Daytime energy improves. Blood pressure tends to drop a few millimeters. Atrial fibrillation becomes easier to control. Some HFrEF patients see modest pump function gains over months of consistent use. Hospital readmissions tend to drop in patients who actually use the machine.

The catch is the actual use. CPAP only works for the hours you wear it. The literature is full of patients who get the machine, struggle with the mask, and quietly stop using it. If you start CPAP, give it a fair trial. The first two weeks are usually the hardest. Mask fit is the single biggest determinant of long-term use, and modern masks are far better than they were ten years ago. If your mask leaks or hurts, that is a fixable problem worth pushing back on with your sleep clinic. The goal is something you actually want to wear most nights.

The data on CPAP in pure central sleep apnea are weaker. Some patients with mostly central events do improve on CPAP. Many do not.

A Cautionary Tale About Adaptive Servo-Ventilation in Weak-Pump Heart Failure

Adaptive servo-ventilation (ASV) is a more sophisticated breathing machine than CPAP. Instead of one steady pressure, it senses your breathing pattern and varies pressure breath by breath, smoothing out the cycling pattern that is the signature of central sleep apnea and Cheyne-Stokes breathing. On paper it looked perfect for heart failure patients with central apnea. For years we used it that way.

Then a major randomized trial set out to prove the benefit in heart failure patients with reduced pump function (LVEF at or below 45 percent) and predominantly central sleep apnea. The result was the opposite of what was expected. The treatment group, on ASV, had a higher rate of cardiovascular death than the control group. The increase was meaningful. The trial was stopped, and the FDA issued a warning. ASV is now contraindicated in patients with symptomatic HFrEF and predominantly central sleep apnea.

Why a treatment that fixed the breathing pattern made outcomes worse is still debated. The most likely explanation is that central sleep apnea in HFrEF is a kind of compensation for a struggling heart, with elevated breathing rates serving a purpose we did not fully understand. Forcing the breathing into a more normal pattern may have removed something the system was relying on. Whatever the mechanism, the lesson is that more sophisticated is not always better.

A 2024 trial tested ASV against usual care across a broader heart failure population. It did not show the harm seen earlier, and did not show a clear benefit. ASV remains contraindicated in symptomatic HFrEF with mostly central apnea, can be considered in selected HFpEF patients or those with stubborn obstructive disease, and is not first-line.

If your sleep doctor or cardiologist is considering ASV, ask which type of heart failure you have and which type of apnea predominates. The answers should match a setting where ASV is reasonable.

Other Tools for Obstructive Sleep Apnea

Not every patient with OSA wants or tolerates CPAP. There are real alternatives, and several of them work well in selected cases.

Weight loss. The single biggest non-CPAP lever for obstructive sleep apnea is body weight. Excess soft tissue around the neck and tongue is what makes the airway prone to collapse during sleep. A 10 percent reduction in body weight can drop the AHI by 20 to 30 percent in many patients. Patients who reach a healthy BMI sometimes resolve their apnea entirely. The newer obesity medications, including GLP-1 receptor agonists, are starting to make this more achievable for patients who could not get there with diet and exercise alone, and the data on apnea improvement with these drugs are encouraging.

Positional therapy. Some people only have apnea when they sleep on their back. The airway collapses with gravity in that position and stays open on the side. A positional sleep study will tell you if that is your pattern. Devices that buzz when you roll onto your back, or wedge-style pillows, can help. For purely positional OSA in mild to moderate cases, this approach can be enough.

Mandibular advancement devices. A custom dental appliance pushes the lower jaw forward a few millimeters during sleep, opening the back of the airway. These work best for mild to moderate OSA and for patients who cannot tolerate CPAP. Fitting is done by a dentist trained in sleep medicine, and the appliance needs follow-up to confirm the apnea actually responded.

Hypoglossal nerve stimulation. An implanted device, similar in spirit to a pacemaker, that activates the tongue muscle in sync with breathing to keep the airway open. Reasonable for selected patients with moderate to severe OSA who cannot use CPAP, with specific anatomy and BMI requirements. The long-term data are decent.

Optimizing Heart Failure Itself Often Improves the Apnea

A point that gets lost: in heart failure with central sleep apnea, treating the heart failure itself often reduces the apnea. The breathing instability that produces Cheyne-Stokes breathing comes from a slow, weak circulation. As the heart pumps more efficiently, the breathing control system stabilizes, and the central events decrease.

This is part of why I push hard on the four pillars of HFrEF therapy: an ARNI or ACE inhibitor or ARB, a beta blocker, an aldosterone antagonist, and an SGLT2 inhibitor. Patients started on the full regimen often see their central sleep apnea improve over months. Patients with severe HFrEF who go on to receive a cardiac resynchronization device sometimes see central events fall by half or more. A heart transplant tends to eliminate Cheyne-Stokes breathing in most recipients.

For HFpEF, the picture is more mixed. Optimizing diuretic management, treating hypertension and AFib, addressing weight, and using SGLT2 inhibitors all help. Sleep apnea in HFpEF tends to be more obstructive than central, which means CPAP is more relevant. Sleep apnea in heart failure is not a separate disease bolted onto a separate problem. It is part of the same physiology, and treating one branch lifts the other.

Common Misconceptions

A few patterns I hear in clinic that I want to address head-on.

"I do not snore, so I cannot have sleep apnea." Central sleep apnea does not snore. The chest goes quiet. Many patients with central apnea have partners who describe pauses in breathing without the snoring, gasping pattern. Snoring is a pointer to obstructive disease. Its absence does not rule out apnea, especially in heart failure.

"I am tired, but I sleep eight hours, so it is not my sleep." Sleep apnea fragments your sleep without waking you up. You can spend eight hours in bed and get the rest of someone who slept four. The number of hours is not the question. The quality of those hours is.

"I tried CPAP for a week and could not sleep with it. It is not for me." The first week is the hardest, and a poor mask fit is the most common reason for failure. Modern masks are far more comfortable than ten years ago, and a good sleep clinic will work with you on fit, pressure, humidification, and ramp settings. Give it a real trial. Many patients who hated it at first end up wearing it without thinking about it after a month.

"If I cut back on salt and sleep with my head propped up, I do not need a sleep study." Those are reasonable heart failure habits. They will not fix sleep apnea. Apnea is a mechanical and neurological problem that needs its own diagnosis and its own treatment.

Frequently Asked Questions

Do I really need a sleep study if I feel fine?

In heart failure, yes, often. Many patients with severe sleep apnea do not feel sleepy. They feel low energy, foggy, mildly depressed, or just older than they used to. A sleep study is the only way to know whether the apnea is part of why your heart is struggling. Treating it can change your daytime energy and your cardiac trajectory.

How long does a CPAP take to start helping me feel better?

Some patients feel a difference within a few days of consistent nightly use. Most feel a clear shift within two to four weeks. Daytime energy and morning headaches usually respond first. Blood pressure and cardiac measures change over months. Stick with it through the adjustment phase.

Can sleep apnea be cured, or is CPAP for life?

Some forms of OSA respond to weight loss, jaw advancement, or hypoglossal nerve stimulation, and a portion of patients do come off CPAP. Many patients use CPAP long term, the same way many patients take blood pressure medication long term. The goal is the cleanest result for your heart, not a particular machine status.

My partner has Cheyne-Stokes breathing patterns at night. What does that mean for them?

In a person with heart failure, Cheyne-Stokes breathing usually points to central sleep apnea and reflects the heart not pumping efficiently enough for the breathing control system. It is a real finding worth telling the cardiologist. Treatment focuses first on optimizing the heart failure itself, with selective use of breathing devices in patients who continue to have severe events after the heart is fully treated.

If I have AFib and sleep apnea, will treating the apnea fix the AFib?

Treating the apnea will not always eliminate AFib, and it makes everything else we do work better. Patients on consistent CPAP have lower rates of AFib coming back after ablation, lower rates of progression from intermittent to permanent AFib, and easier rate and rhythm control on medications. Apnea treatment is part of AFib treatment, not a substitute.

Is the home sleep test good enough, or do I really need an in-lab study?

For uncomplicated obstructive sleep apnea screening in someone without heart disease, a home test is reasonable. In heart failure, the in-lab study is more often the right first move because it can tell central from obstructive events with confidence and capture the full breathing pattern. Talk with your cardiologist or sleep doctor about which makes sense for you.

My sleep doctor mentioned an ASV machine. Is that the same as CPAP?

No. ASV varies pressure breath to breath and is designed for central sleep apnea and Cheyne-Stokes breathing. There is a specific group of heart failure patients in whom ASV is contraindicated: those with symptomatic heart failure with reduced pump function (LVEF at or below 45 percent) and predominantly central sleep apnea. A major trial showed harm in that group. If ASV is being considered for you, confirm your ejection fraction and your apnea pattern fit a setting where the trial data support its use.

Will losing weight let me stop using CPAP?

Sometimes, yes. A 10 percent reduction in body weight reduces apnea severity in most patients with obesity-related OSA. Patients who reach a normal BMI may resolve their apnea entirely. Confirm with a repeat sleep study before stopping the machine. Do not stop CPAP based on the scale alone.

References

1. Yancy, Clyde W., Mariell Jessup, Biykem Bozkurt, et al. "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure." Journal of the American College of Cardiology 79, no. 17 (2022): e263-e421.

2. Yeghiazarians, Yerem, Hani Jneid, Jeremy R. Tietjens, et al. "Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement from the American Heart Association." Circulation 144, no. 3 (2021): e56-e67.

3. Cowie, Martin R., Holger Woehrle, Karl Wegscheider, et al. "Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure." New England Journal of Medicine 373, no. 12 (2015): 1095-1105.

4. Bradley, T. Douglas, Gianfranco Parati, R. John Kimoff, et al. "Adaptive Servo-Ventilation for Sleep-Disordered Breathing in Patients with Heart Failure with Reduced Ejection Fraction (ADVENT-HF): A Multicentre, Multinational, Parallel-Group, Open-Label, Phase 3 Randomised Controlled Trial." The Lancet Respiratory Medicine 12, no. 2 (2024): 153-166.

5. Joglar, José A., Mina K. Chung, Anastasia L. Armbruster, et al. "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation." Journal of the American College of Cardiology 83, no. 1 (2024): 109-279.

6. Kapur, Vishesh K., Dennis H. Auckley, Susmita Chowdhuri, et al. "Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline." Journal of Clinical Sleep Medicine 13, no. 3 (2017): 479-504.

7. Patil, Susheel P., Indu A. Ayappa, Sean M. Caples, et al. "Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline." Journal of Clinical Sleep Medicine 15, no. 2 (2019): 335-343.

8. Linz, Dominik, R. Doug McEvoy, Martin R. Cowie, et al. "Associations of Obstructive Sleep Apnea with Atrial Fibrillation and Continuous Positive Airway Pressure Treatment." JAMA Cardiology 3, no. 6 (2018): 532-540.

9. Fein, Adam S., Adelqui Shapero, Vivek Y. Reddy, et al. "Treatment of Obstructive Sleep Apnea Reduces the Risk of Atrial Fibrillation Recurrence after Catheter Ablation." Journal of the American College of Cardiology 62, no. 4 (2013): 300-305.

10. Javaheri, Shahrokh, Ferran Barbe, Francisco Campos-Rodriguez, et al. "Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences." Journal of the American College of Cardiology 69, no. 7 (2017): 841-858.

11. Kaneko, Yasuyuki, John S. Floras, Kengo Usui, et al. "Cardiovascular Effects of Continuous Positive Airway Pressure in Patients with Heart Failure and Obstructive Sleep Apnea." New England Journal of Medicine 348, no. 13 (2003): 1233-1241.

Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.